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ABSTRACT
Background: Glucose is a major oxidative substrate for intestinal
energy generation in neonatal animals; however, few data in preterm
infants are available. Early administration of enteral nutrition, in-
cluding glucose, may be an effective strategy to support intestinal
adaptation to extrauterine life in preterm neonates.
Objective: The purpose of the present study was to quantify the
first-pass uptake and oxidation of glucose by the splanchnic tissues
(intestine and liver) in human neonates.
Design: Eight preterm infants [birth weight (x  SD): 1.19 
0.22 kg, gestational age: 291 wk] were studied while they received
2 different enteral intakes (A: 40% enteral, 60% parenteral, total
glucose intake 7.5 0.5 mg · kg1 · min1, and B: 100% enteral,
total glucose intake 7.8 0.4 mg · kg1 · min1). Splanchnic and
whole-body glucose kinetics were measured by use of dual-tracer
techniques.
Results: During both feeding periods, approximately one-third of
dietary glucose intake was utilized during the first pass by the
splanchnic tissues. More than three-quarters of this utilized glucose
was oxidized in both periods (79 36% with A and 84 45% with
B). Whole-body glucose oxidation was substantial under both cir-
cumstances: 72  5% and 77%  6% of the glucose flux was
oxidized during partial (A) and full (B) enteral feeding, respectively.
Conclusions: Approximately one-third of dietary glucose is utilized
during the first pass by the splanchnic tissues, irrespective of the
dietary intake. Most of the utilized glucose is used for energy
generation. Am J Clin Nutr 2004;79:831–7.
KEY WORDS Enteral nutrition, first-pass glucose uptake, in-
testine, oxidation, parenteral nutrition, preterm infants, stable iso-
topes
INTRODUCTION
In utero, the fetus receives nutrients continuously via the um-
bilical vein. After birth, newborns undergo several physiologic
adaptations to adjust to their extrauterine environment. In par-
ticular, they must adapt to a shift from glucose as the major
energy source to a carbohydrate-fat mixture as the energy source
(1, 2). Therefore, neonates have to mobilize stores of carbohy-
drates, proteins, and lipids in adequate amounts to meet their
substantial metabolic needs. Energy expenditure in neonates is
3 times higher per unit of body mass than in adults (3).
Studies in several mammalian species have shown that the
portal-drained viscera (the intestines, pancreas, spleen, and
stomach) account for 35% of whole-body energy expenditure,
whereas they contribute  5% of total body weight (4–6). In
contrast, no studies in humans have been performed to quantify
the substrates that are used as fuel sources by the intestine. This
information is critical, especially in situations in which the in-
testine is damaged, eg, by infection, chemotherapy, necrotizing
enterocolitis, or asphyxia. Moreover, identifying the substrates
used to favor this high oxidative activity is important when the
intestine is atrophied, eg, after periods of prolonged total paren-
teral nutrition or directly postpartum in preterm neonates. Know-
ing the required oxidative substrates can help to quickly reestab-
lish gut function, because the appropriate substrates can be
applied.
The extent to which orally administered nutrients are absorbed
by the intestine and are metabolized within the splanchnic tissues
(intestine and liver) or transported to the systemic circulation can
be determined by the use of dual-stable-isotope-tracer methods.
Recently, using this technique in neonatal pigs, we showed that
under normal feeding conditions, the portal-drained viscera ex-
tract 6% of the dietary glucose intake (7). Studies in healthy
adults showed that a similar fraction of the oral glucose load
(10%) is utilized by the splanchnic tissues, and that 90% of the
dietary glucose is available for the peripheral tissues (8). In
preterm neonates, however, little is known about first-pass glu-
cose uptake by the splanchnic tissues.
We found in neonatal pigs that intestinal energy production
during a normal protein intake is largely derived from the oxi-
dation of glucose and amino acids (7, 9, 10). During protein
restriction, the intestines maintain their high rate of energy me-
tabolism, although amino acid oxidation is significantly reduced
and intestinal glucose oxidation becomes more important.
In an oxidation study in parenterally fed preterm infants during
the first weeks of life, we also showed that, on a whole-body
level, glucose is an important fuel source that accounts for 30–
40% of energy expenditure, whereas protein oxidation accounts
for 10–15%. The remaining 40–50% was probably due to lipid
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oxidation (11, 12). Whether glucose is catabolized by the intes-
tinal and hepatic tissues in neonates has not yet been studied.
In the present study, the dual-stable-isotope-tracer technique
was used to examine splanchnic and whole-body glucose kinet-
ics in preterm infants. We hypothesized that, as in piglets, dietary
glucose would be an important source of energy for the neonatal
gut, especially when dietary protein intake is limited. Specifi-
cally, the study was designed to determine first-pass glucose
uptake and oxidation by the splanchnic tissues during the provi-
sion of 2 different enteral formulas.
SUBJECTS AND METHODS
Subjects
Patients eligible for the present study were premature infants
with birth weights ranging from 750 to 1500 g who were appro-
priate for gestational age according to the charts of Usher and
McLean (13). Exclusion criteria were congenital anomalies, gas-
trointestinal or liver diseases, and maternal diabetes. The study
protocol was approved by the Erasmus University Institutional
Review Board, and written informed consent was obtained from
the infants’ parents.
Eight preterm infants were included in the study (Table 1).
CRIB scores (the critical risk index for babies, an indication of
illness; range: 0–23; 14) on the first day of life were all 2. The
infants received a nutrient regimen according to our feeding
protocol; a combination of breast or formula feeding (Nenatal;
Nutricia, Zoetermeer, Netherlands; 0.024 g protein/mL, 0.077 g
carbohydrate/mL, and 0.044 g fat/mL) and parenteral nutrition
containing glucose (10% glucose), amino acids (10% Primene;
Clintec Benelux NV, Brussels), and lipids (20% Intralipid; Fre-
sensius Kabi, Den Bosch, Netherlands). Nenatal was given as
sole enteral nutrition 12 h before the start of the study and during
the study days.
Protocol
To investigate the influence of enteral intake and postnatal age
on splanchnic glucose uptake, the study was implemented in 2
periods on 2 consecutive study days. During period A (age: 6
1 d), the infants received 40% enteral feeding and 60% parenteral
feeding continuously through intragastric and intravenous cath-
eters, respectively. During period B (age: 13  2 d), they re-
ceived full enteral feeding through an intragastric catheter (Fig-
ures 1 and 2). During period A, the infants were implanted with
both an arterial and an intravenous catheter for the infusion of
tracers and the withdrawal of blood samples. During period B, a
peripheral intravenous catheter was available for the infusion of
tracers, and blood samples were collected by heel stick. To col-
lect breath samples from these infants, we used the method de-
scribed by Perman et al (15), who used a nasal tube. This method
has been used in children (15) and preterm infants for the col-
lection of expiratory carbon dioxide after the administration of
13C-labeled substrates (16, 17). We validated this technique for
use in oxidation studies in preterm infants (18). Briefly, a 6
French gastric tube (6 Ch Argyle; Sherwood Medical, Tul-
lamore, Ireland) was placed 1-1.5 cm into the nasopharynx, and
a 15-mL sample of end-tidal breath was taken slowly with a
syringe. Duplicate aliquots of expired air from each sampling
point were stored in evacuated tubes for analysis.
Isotope infusion
Three different stable-isotope infusions were performed during
each study day. First, a primed 2-h infusion of [13C]bicarbonate
(99.0 mol% 13C; Cambridge Isotopes, Woburn, MA) dissolved in
TABLE 1
Characteristics of the subjects included in the study1
Value
Gestational age (wk) 29 1
Birth weight (kg) 1.19 0.22
CRIB score2 1 1
Postnatal age (d)
Period A 6 1
Period B 13 2
Study weight (kg)
Period A 1.11 0.18
Period B 1.18 0.21
1 All values are x  SD; n 8.
2 Critical risk index for babies; range: 0–23 (14).
FIGURE 1. Overview of study period A during study days 1 and 2. IG, intragastric; IV, intravenous.
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sterile saline (10.02mol/kg and 10.02mol · kg1 · h1, concen-
tration measured after administration) was administered at a con-
stant rate. The [13C]bicarbonate infusion was immediately followed
by 2 primed 5-h infusions (10.0mol/kg and 5.0mol · kg1 · h1)
of [U-13C]glucose (99.0 mol% 13C; Cambridge Isotopes) and
[D2]glucose (98.0 mol% 13C; Cambridge Isotopes), which were
designed to assess whole-body and splanchnic glucose kinetics.
During both period A and period B, we administered the tracers in
the following order (Figures 1 and 2): on study days 1 and 4,
[U-13C]glucose was given via an intravenous catheter and
[D2]glucose via the intragastric catheter. On study days 2 and 3, the
intravenousand intragastric routeswereswitched.All isotopeswere
testedandwerefoundtobesterileandpyrogen-freebeforeuse inour
studies. To quantify the effect of postnatal age on whole-body and
splanchnic glucose kinetics, we performed a separate study on the
fourth study day (Figure 2). The first 5 h, the infants received full
enteral feeding simultaneously with 2 labeled glucose tracers intra-
venously and intragastrically; the next 5 h the infants received 40%
enteral and 60% parenteral feeding simultaneously with 2 labeled
glucose tracers intravenously and intragastrically. At time zero,
baseline blood and breath samples were collected. During the last
hour of each tracer infusion, breath samples were collected at 15-
min intervals, and blood samples were obtained at 390 and 420 min.
The total amount of blood withdrawn during a study day was 1.5
mL, which is 2% of blood volume in a 1000-g infant. Blood was
centrifuged immediately (10 min, 0 °C, and 8000  g) and was
stored at70 °C for further analysis.
Analytic methods
Blood samples were prepared for mass spectrometry with the
penta-acetate derivative of glucose: 50 L plasma was mixed
with 200 L ice-cold acetone. After being kept refrigerated for
10 min, the solution was centrifuged through a 10-kDa cutoff
filter for 10 min at 0 °C and 8000g. The filtrate was dried under
vacuum, and 50 L acetic anhydride:pyridine (2:1, by vol) was
added. Thereafter, gas chromatography–mass spectrometry was
performed. The analyses were performed with a 6890 series gas
chromatograph linked to a model 5973 quadrupole mass spec-
trometer (Hewlett-Packard, Palo Alto, CA). Breath samples were
analyzed for enrichment of 13CO2 on an isotope ratio mass spec-
trometer (ABCA; Europa Scientific, Van Loenen Instruments,
Leiden, Netherlands) (19).
Calculations
Plasma enrichments of glucose were used to calculate the rate
of glucose turnover. The rate of glucose turnover was calculated
by measuring the tracer dilution at steady state as modified for
FIGURE 2. Overview of study period B during study days 3 and 4. IG, intragastric; IV, intravenous.
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stable isotope tracers, as previously described (20, 21).
Glucose flux was calculated according to the following equa-
tion:
QIV IIV tracer IEinf/IEIV 1 (1)
where QIV is the flux of the intravenous glucose tracer
(mol · kg1 · h1), IIV tracer is the intravenous glucose tracer
infusion rate in mol · kg1 · h1, IEinf is the isotopic enrich-
ment [mole percent excess (MPE)] of the infusate, and IEIV is
the plasma isotopic enrichment (MPE) of the glucose tracer at
steady state.
First-pass glucose uptake by the splanchnic tissues was cal-
culated according to the expression (22, 23):
First-pass uptake IEIV IEIG/IEIV
enteral intake (2)
where first-pass glucose uptake is expressed in mol · kg1 · h1,
IEIG is the plasma isotopic enrichment of the intragastric glucose
tracer at steady state, and enteral intake is expressed in
mol · kg1 · h1.
Under steady-state conditions, the rate of glucose appearance
is equal to the rate of glucose disappearance. Glucose can enter
the glucose pool by intravenous or enteral glucose infusion and
by glucose production from other substrates (eg, glycerol, gly-
cogen, and amino acids). The glucose production rate can be
calculated as follows:
GPR QIV total glucose intake (3)
where GPR is the glucose production rate in mol · kg1 · h1
and total glucose intake (enteral and intravenous) is also in
mol · kg1 · h1.
Whole-body carbon dioxide production was estimated as fol-
lows:
Whole-body CO2 production Ibicarbonate
[(IEbicarbonate infusate/IEbreath) 1] (4)
where Ibicarbonate is the infusion rate of NaH13CO3
(mol · kg1 · h1), IEbicarbonate infusate is the enrichment (MPE)
of [13C]bicarbonate in the bicarbonate infusate, and IEbreath is the
breath 13CO2 enrichment at plateau during the NaH13CO3 infu-
sion (MPE).
Splanchnic and whole-body glucose oxidation rates were de-
termined by assuming that carbon dioxide production during the
NaH13CO3 infusion was equal to carbon dioxide production dur-
ing the [U-13C]glucose infusion. By determining the increase in
13CO2 enrichment of each individual infant during both the
NaH13CO3 infusion and the [U-13C]glucose infusion, variance
can be diminished and there is no need for a correction factor (24)
to account for [13C]bicarbonate sequestration in the whole body
(11, 25).
As described previously, glucose oxidation was calculated by
multiplying the recovery of the 13C label in the expiratory air with
the rate of appearance of glucose (11). The fraction of glucose
oxidized was measured according to the following equation:
Fraction of glucose oxidized [IEIV Ibicarbonate]/
[IEbreath IIVtracer 6] (5)
where IEbreath is the 13CO2 breath enrichments (MPE) at steady
state during the NaH13CO3 infusion. The denominator is multi-
plied by a factor of 6 to account for the number of labeled carbon
atoms.
Whole-body glucose oxidation was then calculated as follows:
Whole-body glucose oxidation Equation 5
Equation 1 (6)
The calculation of the metabolism of enterally administered
[U-13C]glucose to carbon dioxide is complicated by the fact that
some of the intragastric glucose tracer is absorbed and transferred
to the systemic circulation and thereby labels the arterial pool.
Thus, the non-first-pass oxidation of [13C]glucose that was ad-
ministered enterally but was absorbed and entered the body on
the following study day can be calculated as follows:
Non-first-pass oxidation of the enteral administered
[U-13C] glucose IEIG/IEIV Equation 6 (7)
where IEIG is the tracer enrichment (MPE) in plasma during the
intragastric [13C]glucose infusion on study days 2 and 3, and IEIV
is the tracer enrichment (MPE) in plasma during the intravenous
[13C]glucose infusion on study days 1 and 4.
Total glucose oxidation on study days 2 and 3 is calculated as
described previously:
Total glucose oxidation  recovery (Equation 5)
QIV D2 (8)
where QIV D2 is the flux of the intravenous [D2]glucose tracer
(mol · kg1 · h1).
First-pass glucose oxidation by the splanchnic tissues can thus
be calculated with the following equation:
First-pass glucose oxidation  Equation 8
Equation 7 (9)
Statistics
Data are expressed as the mean values (SEM) obtained from
samples taken over the last hour of each tracer infusion. All
analyses were conducted by using SPSS 10/PC (SPSS Inc, Chi-
cago). Statistical comparisons were performed with a paired
Student’s t test whenever the results were normally distributed.
In cases of apparent nonnormality, a Mann-Whitney U test was
performed. P values 0.05 were considered statistically signif-
icant.
RESULTS
All infants were appropriate for gestational age because of the
inclusion criteria (mean gestational age: 29  1 wk; Table 1).
Two infants were mechanically ventilated during both periods,
and 6 infants received supplemental oxygen through a nasal
prong. All infants received caffeine, therapeutic plasma concen-
trations of which were within the normal range, and all infants
were clinically stable at the time of the study. The infants did not
receive any vasopressors that could influence splanchnic blood
flow. Seven infants had received antenatal steroids. The results of
routine blood chemistry and hematology tests (measurements of
electrolytes, calcium, glucose, acid base, hematocrit, thrombo-
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cyte count, and white blood cell count) were all within normal
limits for preterm infants, and there were no significant changes
in these variables for 24 h before and after the study.
Intakes of glucose and energy are shown in Table 2. By study
design, no significant differences were found in protein and car-
bohydrate intakes during periods A and B, respectively (protein:
3.4  0.1 and 3.2  0.2 g · kg1 · d1; glucose: 7.5  0.5 and
7.8 0.4 mg · kg1 · min1). Fat intake was significantly higher
during full enteral feeding (4.7 0.3 g · kg1 · d1 during period
A compared with 5.8 0.3 g · kg1 · d1 during period B; P
0.05), which resulted in a slightly but significantly higher energy
intake (11% greater) during period B.
Isotopic plateau
Glucose kinetics were calculated from the plateau enrichment
values in breath and plasma. Details of the isotopic enrichments
of plasma glucose at baseline and at plateau during periods A and
B are given in Table 3. The background (baseline) recovery of
the 13C label in expiratory air was not significantly different
between the periods: period A, 1.0918 0.0007 APE; period B,
1.0883  0.0018 APE. The 13CO2 enrichment in breath during
[13C]sodium bicarbonate infusion rose rapidly during the first
hour of infusion in both periods to become constant in all infants
by 120 min, with 3% variation in plateau values: period A,
1.6 0.5%; period B, 2.0 1.1%. The CV (x  SD) of breath
[13C]glucose enrichment above baseline at plateau was
1.2 0.8% during period A and 1.9 1.0% during period B.
Glucose kinetics
First-pass glucose kinetics in the intestine and liver during
partial and full enteral feeding are summarized in Table 4. First-
pass glucose uptake expressed as a percentage of dietary intake,
ie, fractional first-pass uptake, did not differ significantly be-
tween the 2 feeding periods. More than one-third of dietary intake
was utilized by the splanchnic tissues during both partial and full
enteral feeding. Postnatal age did not influence first-pass glucose
uptake. Postnatal age also did not significantly influence first-
pass glucose uptake when enteral intake was restricted: at a
postnatal age of 5 d and a restricted intake, 44  8% of dietary
intake was utilized; at a postnatal age of 13 d and a restricted
intake, 398% was utilized. During restricted enteral intake, the
splanchnic tissues oxidized dietary glucose at a rate of 323 136
mol · kg1 · h1. During full enteral feeding, glucose oxidation
by the splanchnic tissues was 573273mol · kg1 · h1. Taken
together, the first-pass glucose oxidation was not significantly
different between the 2 feeding periods, and accounted for more
than three-quarters of the utilized glucose.
Whole-body glucose oxidation and glucose production rates
are shown in Table 5. There was no significant difference in the
amount of glucose oxidized by the whole body between the 2
feeding periods. During both intakes, whole-body glucose oxi-
dation accounted for75% of glucose flux: period A, 72 5%;
period B, 77 6%. Postnatal age did not influence whole-body
glucose oxidation: at a postnatal age of 13 d and a restricted
enteral intake, 69  5% of the glucose flux was oxidized. The
glucose production rate was 1500 mol · kg1 · h1 in both
TABLE 2
Glucose and energy intakes during periods A (partial enteral feeding) and
B (full enteral feeding)1
Period A Period B
Total glucose intake (mg  kg1  min1) 7.5 0.5 7.8 0.4
Enteral 2.7 0.3 7.1 0.3
Parenteral 5.0 0.4 0.7 0.1
Total energy intake (kcal  kg1  d1) 100 42 111 5
Enteral 41 5 107 5
Parenteral 58 6 4 1
1 All values are x  SD; n 8.
2 Significantly different from period B, P 0.05 (Student’s t test).
TABLE 3
Baseline and steady-state plasma isotopic enrichments on study days 1 and 2 during period A (partial enteral feeding) and on study days 3 and 4 during
period B (full enteral feeding)1
Period and study day
[U-13C]Glucose [D2]Glucose
Baseline Plateau Baseline Plateau
mol % mol %
Period A
Day 1 0.0192 0.0043 0.1308 0.0610 2.7115 0.0519 2.7729 0.0702
Day 2 0.0199 0.0039 0.1135 0.0629 2.7347 0.0720 2.7883 0.0715
Period B
Day 3 0.0199 0.0073 0.1309 0.0644 2.6702 0.0735 2.8245 0.0955
Day 4 — 0.1895 0.0497 — 2.7621 0.0604
Period A
Day 4 0.0166 0.0032 0.1739 0.0262 2.6725 0.0258 2.7780 0.0430
1 All values are x  SD; n 8. The baseline enrichments on the different study days were not significantly different (Student’s t test). On study days 1
and 4, [U-13C]glucose was administered intravenously and [D2]glucose intragastrically; on study days 2 and 3, [U-13C]glucose was given intragastrically and
[D2]glucose intravenously.
TABLE 4
First-pass (FP) glucose uptake and oxidation by the splanchnic tissues
during periods A (partial enteral feeding) and B (full enteral feeding)1
Period A Period B
FP uptake (mol  kg1  h1) 398 65 825 253
Fractional FP uptake (%) 44 8 32 9
FP oxidation (mol  kg1  h1) 323 136 573 273
Fractional FP oxidation of FP uptake (%) 79 36 84 45
1 All values are x SEM; n 8. Absolute and fractional FP uptake and
oxidation were not significantly different between periods (Mann Whitney U
test).
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periods, and accounted for 40 3% and 62 6% of the glucose
flux in periods A and B, respectively.
DISCUSSION
To our knowledge, this is the first study to provide insight into
both splanchnic glucose uptake and splanchnic oxidative capac-
ity in preterm infants. Our data indicate that the splanchnic tis-
sues (which include both the intestine and the liver) utilize one-
third of oral glucose intake, irrespective of the level of enteral
feeding. Approximately 80% of the utilized glucose is oxidized,
presumably to sustain the high rate of visceral metabolism.
Whole-body glucose oxidation accounted for three-quarters of
the glucose turnover. Given that splanchnic glucose oxidation
was substantial in the early weeks of life, early administration of
enteral nutrition, including glucose, may be an effective strategy
to support intestinal adaptation to extrauterine life in preterm
neonates. These data show that the splanchnic tissues extract a
disproportionate amount of dietary glucose to serve mainly as a
fuel source in the early life of preterm neonates.
Neonates depend on the gastrointestinal tract for the acquisi-
tion of nutrients through the processes of propulsion, digestion,
and absorption of ingested food. Studies in adults showed 500
mg of residual glucose in gastric washings obtained 3 h after the
ingestion of 100 g oral glucose (26). Furthermore,  98% of
glucose is removed from the intestinal lumen before it reaches the
ileum (27). However, glucose was not the sole source of carbo-
hydrates in the present study; the formula also contained lactose,
maltose, and glucose polymers. Others have shown that glucose
polymers are well absorbed by young infants (28, 29). Kien et al
(30) showed that lactose digestion from formula was 79%,
although there was a significant linear correlation between lac-
tose digestion and postconceptional age. Thus, most of the di-
etary milk carbohydrates are absorbed by the intestinal mucosa at
a postnatal age of 1 wk. Therefore, glucose that does not appear
in the systemic circulation is utilized by the intestine and liver and
is not lost via the feces before being used for synthetic purposes.
The substantial dietary glucose uptake observed during both
partial and full enteral feeding reflects the use of absorbed glu-
cose for different splanchnic metabolic fates, at least under clin-
ically stable conditions and in the absence of significant intestinal
diseases. Splanchnic glucose extraction equals the sum of intes-
tinal and hepatic glucose extraction. Any combination of the
following 4 possibilities could explain the lower systemic avail-
ability of the dietary glucose: 1) glucose is used by mucosal tissue
as a energy-providing substrate; 2) glucose is used for the syn-
thesis of intestinal glycoproteins; 3) in the process of absorption,
some glucose is converted into three-carbon compounds, which
are then released into the portal vein; and 4) glucose is taken up
and metabolized by the liver. It should be emphasized quite
clearly that catheterization of the portal vein was not ethically
feasible in the small infants we studied. Consequently, it was not
possible to quantify the net hepatic uptake of dietary glucose and
the relative contributions of intestinal and hepatic tissues to the
splanchnic glucose oxidation.
By using dual-stable-isotope methodology, we were able to
measure first-pass glucose oxidation by the intestine and liver,
and we found that more than three-quarters of the intestinally
absorbed glucose was oxidized. Thus, it seems that dietary glu-
cose is an important energy source for the splanchnic mucosa.
The present data on intestinal glucose oxidation agree with our
previous observations in protein-restricted piglets, in which we
found that intestinal glucose oxidation accounts for50% of the
total visceral carbon dioxide production (7). Similarly, in vitro
studies with human enterocytes reported that the respiratory fuels
of human enterocytes include glucose, glutamine, and, to a lesser
extent, ketone bodies as indicated in the proportion of oxygen
consumption attributed to these fuels (31).
A second metabolic fate of the glucose utilized during the first
pass might be mucin synthesis. Intestinal mucins are key com-
ponents of the first line of host defense against intestinal patho-
gens. These large glycoproteins secreted by specialized goblet
cells form viscous gels that trap microorganisms and limit their
diffusion to the intestinal epithelium. Isolated mucin has high
concentrations of carbohydrates, representing 65% of the mucin
by weight (32, 33). Recently, we found in preterm infants that
 80% of the dietary threonine intake was utilized in the first
pass, which was not used for oxidative purposes but for synthetic
purposes (SRD van der Schoor, unpublished observations,
2003). Therefore, we speculate that preterm neonates have a high
visceral need for threonine, presumably for the synthesis of (gly-
co)proteins, and, consequently, that neonates may have a high
need for glucose as well.
After its splanchnic release into the systemic circulation, glu-
cose can be oxidized in the peripheral tissues, metabolized to
lactate and recycled to glucose via gluconeogenesis, stored as
glycogen, or used in various synthetic processes. Because glu-
cose represents the main source of energy for preterm infants
during most of the neonatal period, it is important to determine
the extent of whole-body glucose oxidation and its contribution
to total glucose use. This knowledge assists in the clinical deter-
mination of the optimal rate of glucose infusion for preterm
infants, which is the rate that is appropriate to the neonate’s
capacity to oxidize glucose. In the present study, we quantified
the whole-body oxidation of glucose and the glucose production
rate in relation to an increasing enteral intake. Our results show
that 70% of the glucose turnover is oxidized, and these obser-
vations are similar to other studies, except for the study done by
Cowett et al (34). In preterm infants, we and others previously
showed that 50–65% of the whole-body glucose turnover was
oxidized (10, 35, 36). Cowett et al (34) studied glucose oxidation
in preterm infants of different postnatal ages and found that the
fraction of glucose oxidized decreased with postnatal age. We
did not find a significant effect of postnatal age on whole-body
glucose oxidation, which might be because the infants we studied
differed in age by only 7 d. However, the purpose of this part of
TABLE 5
Whole-body (WB) glucose kinetics in preterm infants during periods A
(partial enteral feeding) and B (full enteral feeding)1
Period A Period B
6 d old 13 d old 13 d old
mol  kg1  h1 mol  kg1  h1
IV flux 3405 220 3108 295 2885 233
WB oxidation 2522 331 2305 163 2161 101
WB oxidation of flux (%) 72 5 69 5 77 6
GPR 1433 255 1343 146 1781 221
1 All values are x  SEM; n  8. IV, intravenous; GPR, glucose pro-
duction rate. WB glucose kinetics was not significantly different between
periods (Student’s t test).
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the study was to show that glucose metabolism did not differ by
postnatal age or feeding pattern.
In conclusion, we showed that the splanchnic tissues extract
one-third of the dietary glucose intake in preterm infants in their
first weeks of life. A significant amount of this utilized glucose
is used for oxidative purposes by the intestine and liver. Our
results also show that neither the amount of enteral feeding nor
postnatal age significantly affects glucose uptake and oxidation
by the splanchnic tissues. Taken together, these results highlight
the critical importance of the splanchnic tissues in actively reg-
ulating glucose flow to the peripheral tissues in the first weeks of
life in preterm neonates.
SRDvdS collected and analyzed the data and wrote the manuscript; BS and
DLW analyzed the data; HAB, DT, and DGB provided helpful comments in
writing the manuscript; and JBvG designed the study and provided helpful
comments in writing the manuscript. None of the authors had any financial or
personal interest in any company or organization sponsoring the research.
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